Chronic Hepatitis E as a cause for cryptogenic cirrhosis in HIV

Journal of Infection

Volumn 66, Issue 1, 2013, Pages 103-106

  Jagjit Singh, Gurmit K ^a   Ijaz, Samreen ^b   Rockwood, Neesha ^a   Farnworth, Simon P ^a   Devitt, Emma ^a   Atkins, Mark ^a   Tedder, Richard ^b   Nelson, Mark ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

Hepatitis E; HIV; Immunosuppression; Liver; Pegylated interferon; Transaminitis

Indexed keywords

ALANINE AMINOTRANSFERASE; EFAVIRENZ; EFAVIRENZ PLUS EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; LAMIVUDINE; PEGINTERFERON ALPHA2A; VIRUS RNA; ZIDOVUDINE;

ADULT; ARTICLE; CASE REPORT; CD4 LYMPHOCYTE COUNT; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ELASTOGRAPHY; HEPATITIS E; HEPATOSPLENOMEGALY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTRANSAMINASEMIA; LETHARGY; LIVER BIOPSY; LIVER CIRRHOSIS; MALE; MALE HOMOSEXUAL; VIREMIA; VIRUS LOAD;

ANTIVIRAL AGENTS; ELASTICITY IMAGING TECHNIQUES; HEPATITIS ANTIBODIES; HEPATITIS E; HEPATITIS, CHRONIC; HIV INFECTIONS; HUMANS; INTERFERON-ALPHA; LIVER CIRRHOSIS; MALE; MIDDLE AGED; POLYETHYLENE GLYCOLS;

EID: 84870728152     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2011.11.027     Document Type: Article

References (31)

1. Kamar N., Selves J., Mansuy J.M., Ouezzani L., Peron J.M., Guitard J., et al. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl J Med 2008, 358(8):811-817.
2. Gerolami R., Moal V., Picard C., Colson P. Hepatitis E virus as an emerging cause of chronic liver disease in organ transplant recipients. J Hepatol 2009, 50(3):622-624.
3. Pischke S., Suneetha P.V., Baechlein C., Barg-Hock H., Heim A., Kamar N., et al. Hepatitis E virus infection as a cause of graft hepatitis in liver transplant recipients. Liver Transpl 2010, 16:74-82.
4. Haagsma E.B., van den Berg A.P., Porte R.J., Benne C.A., Vennema H., Reimerink J.H., et al. Chronic Hepatitis E virus infection in liver transplant recipients. Liver Transpl 2008, 14:547-553.
5. Gerolami R., Moal V., Colson P. Chronic Hepatitis E with cirrhosis in a kidney transplant recipient. N Engl J Med 2008, 358:859-860.
6. Kamar N., Mansuy J.M., Cointault O., Selves J., Abravanel F., Danjoux M., et al. Hepatitis E virus related cirrhosis in kidney and kidney-pancreas transplant recipients. Am J Transplant 2008 Aug, 8(8):1744-1748.
7. Ollier L., Tieulie N., Sanderson F., Heudier P., Giordanengo V., Fuzibet J.G., et al. Chronic hepatitis after Hepatitis E virus infection in a patient with non-Hodgkin's lymphoma taking rituximab. Ann Intern Med 2009, 150(6):430-431.
8. Dalton H.R., Bendall R., Keane F., Tedder R., Ijaz S. Persistent carriage of Hepatitis E virus in patients with HIV infection. N Engl J Med 2009, 361(10):1025-1027.
9. Colson P., Kaba M., Moreau J., Brouqui P. Hepatitis E in an HIV infected patient. J Clin Virol 2009, 45:269-271.
10. Kaba M., Richet H., Ravaux I., Moreau J., Poizot-Martin I., Motte A., et al. Hepatitis E virus infection in patients infected with the human immunodeficiency virus. J Med Virol 2011, 83:1704-1716.
11. Kenfak-Foguena A., Schoni Affolter F., Burgisser P., Witteck A., Darling K.E.A., Kovari H., et al. Hepatitis E virus seroprevalence and chronic infections in patients with HIV, Switzerland. Emerg Infect Dis 2011, 17:1074-1078.
12. Okamoto H. Genetic variability and evolution of Hepatitis E virus. Virus Res 2007, 127:216-228.
13. Dalton H.R., Bendall R., Ijaz S., Banks M. Hepatitis E: an emerging infection in developed countries. Lancet Infect Dis 2008, 8:698-709.
14. Takahashi K., Kitajima N., Abe N., Mishiro S. Complete or near-complete nucleotide sequences of Hepatitis E virus genome recovered from a wild boar, a deer, and four patients who ate the deer. Virology 2004, 330:501-505.
15. Keane F.E., Gompels M., Bendall R.P., Drayton R., Jennings L., Black J., et al. Hepatitis E virus co-infection in patients with HIV infection. HIV Med 2011, 10.1111/j.1468-1293.2011.00942.x.
16. Ijaz S., Vyse A.J., Morgan D., Pebody R.G., Tedder R.S., Brown D. Indigenous Hepatitis E virus infection in England: more common than it seems. J Clin Virol 2009, 44:272-276.
17. Colson P., Dhiver C., Gerolami R. Hepatitis E virus as a newly identified cause of acute viral hepatitis during human immunodeficiency virus infection. Clinical Microbiology and Infection 2008, 14(12):1176-1180.
18. Curry J.A., Adams N., Crum-Cianflone N.F. Acute Hepatitis E virus infection in an HIV-infected person in the United States. Ann Intern Med 2009, 150(3):226-227.
19. Colson P., Gerolami R., Moreau J., Borentain P., Brouqui P. Concurrent autochthonous acute Hepatitis E and hepatitis B in an HIV-infected patient: one virus may hide another. Int J Infect Dis 2010, 14:e357. 10.1016/j.ijid.2009.04.007.
20. Thoden J., Venhoff N., Miehle N., Klar M., Huzly D., Panther E., et al. Hepatitis E and jaundice in an HIV-positive pregnant woman. AIDS 2008, 22:909-910.
21. Renou C., Lafeuillade A., Cadranel J.F., Pavio N., Pariente A., Allegre T., et al. Hepatitis E virus in HIV-infected patients. AIDS 2010, 24:1493-1499.
22. Sellier P., Mazeron M.C., Tesse S., Badsi E., Evans J., Magnier J.D., et al. Hepatitis E virus infection in an HIV-infected patient with elevated serum transaminase levels. Virol J 2011, 15(8):171.
23. Colson P., Dhiver C., Poizot Martin I., Tamalet C., Gerolami R. Acute and chronic Hepatitis E in patient infected with human immunodeficiency virus. J Viral Hepatol 2011, 18(3):227-228. 10.1111/j.1365-2893.2010.01311.x.
24. Dalton H.R., Keane F., Bendall R., Matthew J., Tedder R., Ijaz S. Treatment of chronic Hepatitis E in a patient with HIV infection. Ann Intern Med 2011, 155(7):479-480.
25. Le Coutre P., Meiserl H., Hoffmann J., Rocken C., Vuong G.L., Neuburger S., et al. Reactivation of Hepatitis E infection with acute lymphoblastic leukaemia after allogeneic stem cell transplantation. Gut 2009, 58(5):699-702.
26. Dalton H.R., Fellows H.J., Stableforth W., Joseph M., Thurairajah P.H., Warshow U., et al. The role of Hepatitis E virus testing in drug-induced liver injury. Aliment Pharmacol Ther 2007, 26:1429-1435.
27. Bonacini M., Lin H.J., Hollinger F.B. Effect of coexisting HIV-1 infection on the diagnosis and evaluation of hepatitis C virus. J Acquir Immune Defic Syndr 2001, 26:340-344.
28. Kamar N., Rostaing L., Abravanel F., Garrouste C., Esposito L., Cardeau-Desangles I., et al. Pegylated interferon-α for treating chronic Hepatitis E virus infection after liver transplantation. Clin Infect Dis 2010, 50(5):e30-e33.
29. Kamar N., Abravanel F., Garrouste C., Cardeau-Desangles I., Mansuy J.M., Weclawiak H., et al. Three-month pegylated interferon-alpha-2a therapy for chronic Hepatitis E virus infection in a haemodialysis patient. Nephrol Dial Transplant 2010, 25:2792-2795.
30. Kamar N., Garrouste C., Haagsma E.B., Garrigue V., Pischke S., Chauvet S., et al. Factors associated with chronic hepatitis in patients with Hepatitis E virus infection who have received solid organ transplants. Gastroenterology 2011, 140(5):1481-1489.
31. Kamar N., Rostaing L., Abravanel F., Garrouste C., Lhomme S., Esposito L., et al. Ribavirin therapy inhibits viral replication in patients with chronic Hepatitis E virus infection. Gastroenterology 2010, 139(5):1612-1618.